切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2022, Vol. 11 ›› Issue (01) : 9 -12. doi: 10.3877/cma.j.issn.2095-3232.2022.01.003

所属专题: 综述

专家论坛

原发免疫性血小板减少症脾切除术疗效评估和预测指标
王雅宁1, 李惜惜1, 解英俊1,()   
  1. 1. 130041 长春,吉林大学第二医院肝胆胰外科
  • 收稿日期:2021-11-11 出版日期:2022-02-10
  • 通信作者: 解英俊
  • 基金资助:
    吉林省卫生与健康技术创新项目(2018J053); 吉林省医疗卫生人才专项(2019SCZT015)

Assessment of therapeutic effect of splenectomy for primary immune thrombocytopenia and its predictor

Yaning Wang1, Xixi Li1, Yingjun Xie1()   

  • Received:2021-11-11 Published:2022-02-10
  • Corresponding author: Yingjun Xie
引用本文:

王雅宁, 李惜惜, 解英俊. 原发免疫性血小板减少症脾切除术疗效评估和预测指标[J/OL]. 中华肝脏外科手术学电子杂志, 2022, 11(01): 9-12.

Yaning Wang, Xixi Li, Yingjun Xie. Assessment of therapeutic effect of splenectomy for primary immune thrombocytopenia and its predictor[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(01): 9-12.

[1]
中华医学会血液学分会血栓与止血学组. 成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)[J]. 中华血液学杂志, 2020, 41(8):617-623.
[2]
Cooper N, Ghanima W.Immune thrombocytopenia[J].N Engl J Med,2019,381(10):945-955.
[3]
Cole TJ.Glucocorticoid action and the development of selective glucocorticoid receptor ligands[J].Biotechnol Annu Rev,2006(12):269-300.
[4]
Vianelli N, Palandri F, Polverelli N,et al.Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years[J].Haematologica,2013,98(6):875-880.
[5]
Zheng D, Huang CS, Huang SB,et al.Laparoscopic splenectomy for primary immune thrombocytopenia: current status and challenges[J].World J Gastrointest Endosc,2016,8(17):610-615.
[6]
Palandri F, Catani L, Auteri G,et al.Understanding how older age drives decision-making and outcome in immune thrombocytopenia. a single centre study on 465 adult patients[J].Br J Haematol,2019,184(3):424-430.
[7]
Fabris F, Tassan T, Ramon R,et al.Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura[J].Br J Haematol,2001,112(3):637-640.
[8]
Navez J, Hubert C, Gigot JF,et al.Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura?[J].Platelets,2015,26(6):573-576.
[9]
Nyilas á, Paszt A, Borda B,et al.Predictive factors for success of laparoscopic splenectomy for ITP[J].JSLS,2018,22(4):e2018.00021.
[10]
Xu T, Li N, Jin F,et al.Predictive factors of idiopathic thrombocytopenic purpura and long-term survival in Chinese adults undergoing laparoscopic splenectomy[J].Surg Laparosc Endosc Percutan Tech,2016,26(5):397-400.
[11]
Kwiatkowska A, Radkowiak D, Wysocki M,et al.Prognostic factors for immune thrombocytopenic purpura remission after laparoscopic splenectomy: a cohort study[J].Medicina,2019,55(4):112.
[12]
Avila ML, Amiri N, Pullenayegum E,et al.Long-term outcomes after splenectomy in children with immune thrombocytopenia: an update on the registry data from the Intercontinental Cooperative ITP Study Group[J].Haematologica,2020,105(11):2682-2685.
[13]
British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy[J]. Br J Haematol, 2003, 120(4):574-596.
[14]
Neunert C, Lim W, Crowther M,et al.The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J].Blood,2011,117(16):4190-4207.
[15]
Rijcken E, Mees ST, Bisping G,et al.Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): a retrospective cohort study on longtime response predicting factors based on consensus criteria[J].Int J Surg,2014,12(12):1428-1433.
[16]
Liu EH, Dilip CK, Yeh TS,et al.Long-term relapse-free rurvival rate and predictive factors of idiopathic thrombocytopenic purpura in adults undergoing splenectomy[J].Biomed J,2013,36(1):23-27.
[17]
Liao R, Tang PY, Song JF,et al.Platelet count on preoperative day 1 predicts the long-term responses to laparoscopic splenectomy for Chinese patients with medically refractory idiopathic thrombocytopenic purpura[J].BMC Surg,2018,18(1):108.
[18]
Pang SJ, Lazarus AH.Mechanisms of platelet recovery in ITP associated with therapy[J].Ann Hematol,2010,89Suppl 1:31-35.
[19]
Najean Y, Rain JD, Billotey C.The site of destruction of autologous111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies[J].Br J Haematol,1997,97(3):547-550.
[20]
Sarpatwari A, Provan D, Erqou S,et al.Autologous111In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry[J].Br J Haematol,2010,151(5):477-487.
[21]
Amini SN, Nelson VS, Sobels A,et al.Autologous platelet scintigraphy and clinical outcome of splenectomy in immune thrombocytopenia: a systematic review and meta-analysis[J].Crit Rev Oncol Hematol,2020(153):103040.
[22]
Zheng CX, Ji ZQ, Zhang LJ,et al.Proteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopenia[J].J Transl Med,2012(10):208.
[23]
Furudoï A, Rivière é, Lazaro E,et al.Adult primary immune thrombocytopenia: spleen histology findings and outcomes according to rituximab use based on analysis of 41 cases[J].Am J Surg Pathol,2018,42(3):401-412.
[24]
胡志平,王东,朱继业. 脾切除术在自身免疫性血液系统疾病治疗中的价值 [J/OL]. 中华肝脏外科手术学电子杂志, 2019, 8(5):400-404.
[25]
Tastaldi L, Krpata DM, Prabhu AS,et al.Laparoscopic splenectomy for immune thrombocytopenia (ITP): long-term outcomes of a modern cohort[J].Surg Endosc,2019,33(2):475-485.
[1] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 奚玲, 仝瀚文, 缪骥, 毛永欢, 沈晓菲, 杜峻峰, 刘晔. 基于肌少症构建的造口旁疝危险因素预测模型[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 48-51.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[6] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[7] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[8] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[9] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[10] 韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
[11] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[12] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[13] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
[14] 董晟, 郎胜坤, 葛新, 孙少君, 薛明宇. 反向休克指数乘以格拉斯哥昏迷评分对老年严重创伤患者发生急性创伤性凝血功能障碍的预测价值[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 541-547.
[15] 黄圣楷, 许斌, 苏健, 孙龙. 海南省2010~2020年乙型肝炎流行趋势的时间序列分析及预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 555-561.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?